Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI116856

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Z Liu, L A Diaz, J L Troy, A F Taylor, D J Emery, J A Fairley, and G J Giudice

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Liu, Z. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Diaz, L. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Troy, J. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Taylor, A. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Emery, D. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Fairley, J. in: JCI | PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Giudice, G. in: JCI | PubMed | Google Scholar

Published November 1, 1993 - More info

Published in Volume 92, Issue 5 on November 1, 1993
J Clin Invest. 1993;92(5):2480–2488. https://doi.org/10.1172/JCI116856.
© 1993 The American Society for Clinical Investigation
Published November 1, 1993 - Version history
View PDF
Abstract

Subepidermal blistering associated with the human skin diseases bullous pemphigoid and herpes gestationis has been thought to be an IgG autoantibody-mediated process; however, previous attempts to demonstrate the pathogenicity of patient autoantibodies have been unsuccessful. An immunodominant and potentially pathogenic epitope associated with these blistering diseases has recently been mapped to the extracellular domain of a human epidermal antigen, BP180. Patient autoantibodies that react with this well-defined antigenic site failed to crossreact with the murine form of this autoantigen and thus could not be assayed for pathogenicity in a conventional passive transfer mouse model. As an alternative, rabbit polyclonal antibodies were generated against a segment of the murine BP180 protein homologous with the human BP180 autoantibody-reactive site and were passively transferred into neonatal BALB/c mice. The injected animals developed a subepidermal blistering disease that closely mimicked bullous pemphigoid and herpes gestationis at the clinical, histological, and immunological levels. Autoantibodies that recognize the human BP180 ectodomain are therefore likely to play an initiatory role in the pathogenesis of bullous pemphigoid and herpes gestationis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2480
page 2480
icon of scanned page 2481
page 2481
icon of scanned page 2482
page 2482
icon of scanned page 2483
page 2483
icon of scanned page 2484
page 2484
icon of scanned page 2485
page 2485
icon of scanned page 2486
page 2486
icon of scanned page 2487
page 2487
icon of scanned page 2488
page 2488
Version history
  • Version 1 (November 1, 1993): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts